Haleon is a pure-play consumer healthcare company focusing on oral health, respiratory health, pain relief, vitamins, supplements, and digestive health across 170 markets. Its products include staples as well as over-the-counter medicines. Haleon was incorporated in 2021 and is headquartered in Brentford, UK.

Earnings season is starting to slow but is by no means over, with multiple big-name and market-moving companies still to report - not to mention the many companies in industries that always bring up the rear in the reporting rotation. As such, the volume of weekly insider transactions reported by Vickers Stock Research remains low at about 1400 transactions that meet the criteria for publication in Vickers' Weekly Insider Report. This compares to well over 2000 weekly transactions when insiders can trade with less restriction. Moving beyond the light volume, the theme of overall insider sentiment this week 'holding steady,' with the major eight-week sell/buy ratios from Vickers little changed from last week and at either neutral or (just barely) bearish readings. On a sector basis, the broader trend is not significantly changed, but there has been some rotation in sentiment. Vickers' sector sentiment has improved modestly, with more sectors reporting bullish one-week sell/buy ratios (three) than are reporting bearish ratios (two). But that, of course, leaves six sector that are neutral. Drilling down, Communication Services, Consumer Staples, and Real Estate all bullish; Energy and Materials are bearish; and Consumer Discretionary, Financial, Healthcare, Industrial, Information Technology, and Utility are all neutral. This result was largely mirrored across the eight-week sell/buy ratios as, week-over-week, the number of neutral sectors increased (to five in total), while the number of bullish and bearish sectors each decreased (to five and one, respectively). This week, analysts at Vickers highlighted insider transactions of interest at Illumina Inc. (NGS: ILMN) and Agilysys Inc. (NGS: AGYS).

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.